# A Trial of HRS5580 in Prevention of Postoperative Nausea and Vomiting of Adults

> **NCT06475846** · PHASE2 · COMPLETED · sponsor: **Fujian Shengdi Pharmaceutical Co., Ltd.** · enrollment: 235 (actual)

## Conditions studied

- Preventing of Postoperative Nausea and Vomiting in Adults

## Interventions

- **DRUG:** HRS5580
- **DRUG:** HRS5580
- **DRUG:** HRS5580
- **DRUG:** Ondansetron
- **DRUG:** blank preparation

## Key facts

- **NCT ID:** NCT06475846
- **Lead sponsor:** Fujian Shengdi Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-25
- **Primary completion:** 2024-10-29
- **Final completion:** 2024-10-29
- **Target enrollment:** 235 (ACTUAL)
- **Last updated:** 2025-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06475846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06475846, "A Trial of HRS5580 in Prevention of Postoperative Nausea and Vomiting of Adults". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06475846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*